Barbara Burtness

27PUBLICATIONS

200CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersTumour immunologyPhycology (incl. marine grasses)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (27)

Sort by Publication Date:

|May 31, 2026

Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.

|Apr 20, 2026

Quantification of Antibody-Drug Conjugate Targets in Head and Neck Squamous Cell Carcinoma.

|Apr 01, 2026

Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer.

Sri Vemulamanda, Aditi Kothari, Loris De Cecco

|Mar 13, 2026

A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950).

Aarti Bhatia, Zhengjia Chen, Yuji Zhang

|Jan 23, 2026

NN-01-195, a novel conjugate of HSP90 and AURKA inhibitors, effectively targets solid tumors.

Theodore T Nguyen, Nitesh K Nandwana, Yellamelli V V Srikanth

|Dec 23, 2025

Automated Lymph Node and Extranodal Extension Assessment Improves Risk Stratification in Oropharyngeal Carcinoma.

Zezhong Ye, Reza Mojahed-Yazdi, Anna Zapaishchykova

Pageof 5

Frequent Collaborators

Robert L Ferris

Nabil F Saba

Amanda Psyrri

Kevin J Harrington

Yael Flamand

Christine H Chung

Gilberto de Castro

Irene Brana

Harry Quon

Douglas R Adkins

Frequent Collaborators

Robert L Ferris

Nabil F Saba

Amanda Psyrri

Kevin J Harrington